Last Updated: 14 Nov 2024
Executive Summary
Elevance Health Inc. (ELV) is a leading health benefits company with a market capitalization of $957.66 billion. The company has strong fundamentals, with a trailing P/E ratio of 15.04, a PEG ratio of 0.791, and a return on equity of 15.5%. Technical analysis suggests that the stock is currently undervalued, with a 52-week low of $397.98 and a 50-day moving average of $483.55. Analysts are bullish on the stock, with a consensus target price of $521.62.
Company Overview
Elevance Health Inc. is headquartered in Indianapolis, Indiana. The company provides a wide range of health benefits products and services, including health insurance, dental insurance, vision insurance, and pharmacy benefits management. Elevance Health Inc. has a strong market position, with over 100 million members.
Fundamental Analysis
Elevance Health Inc. has a strong financial profile. The company's revenue has grown steadily in recent years, reaching $174.02 billion in the trailing twelve months. The company's net income has also grown steadily, reaching $11.35 billion in the trailing twelve months. Elevance Health Inc. has a strong balance sheet, with total assets of $325.75 billion and total debt of $67.67 billion.
Technical Analysis
The technical analysis of Elevance Health Inc. suggests that the stock is currently undervalued. The stock's 52-week low is $397.98, and its 50-day moving average is $483.55. The stock is currently trading below its 200-day moving average of $513.54. The relative strength index (RSI) is currently at 45.67, which indicates that the stock is oversold.
Short Term Outlook
The short-term outlook for Elevance Health Inc. is positive. The stock is currently trading below its fair value, and the technical analysis suggests that the stock is oversold. The company's strong fundamentals and positive analyst sentiment are also supportive of a positive short-term outlook.
Long Term Outlook
The long-term outlook for Elevance Health Inc. is also positive. The company's strong market position, growing revenue, and strong balance sheet are all supportive of a positive long-term outlook. The company's commitment to innovation and its focus on providing affordable healthcare are also positive factors for the long term.
Analyst Recommendations
Analysts are bullish on Elevance Health Inc. The consensus target price is $521.62, which represents a potential upside of 27% from the current price. Seven analysts have a strong buy rating on the stock, 13 have a buy rating, four have a hold rating, and zero have a sell or strong sell rating.
